2006
DOI: 10.1007/s10517-006-0428-1
|View full text |Cite
|
Sign up to set email alerts
|

Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced behavioral manifestations of hyperfunction of dopamine system

Abstract: Peptide anxiolytic selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) applied intraperitoneally in doses of 0.01, 0.1, 1.0, and 10.0 mg/kg to mice reduces behavioral manifestations of dopaminergic system induced by apomorphine in the verticalization test. This effect was comparable to that of atypical antipsychotic olanzapine in near-therapeutic doses (0.1 and 1.0 mg/kg, intraperitoneally) and was blocked with nonselective opioid receptor antagonist naloxone (10 mg/kg, intraperitoneally). Radioreceptor assay showed that sel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…Activation of this gene by Selank at early and later times suggests an ability of the peptide to influence processes involved in synaptic plasticity and thereby render nootropic action. It has been shown previously that Selank modulates dopamine and serotonin receptors, which play a role in the stimulation of mental activity and in the pathogenesis of anxiety (Meshavkin et al, 2006 ).…”
Section: Discussionmentioning
confidence: 99%
“…Activation of this gene by Selank at early and later times suggests an ability of the peptide to influence processes involved in synaptic plasticity and thereby render nootropic action. It has been shown previously that Selank modulates dopamine and serotonin receptors, which play a role in the stimulation of mental activity and in the pathogenesis of anxiety (Meshavkin et al, 2006 ).…”
Section: Discussionmentioning
confidence: 99%
“…However, the direct binding of the peptide to dopamine and opioid receptors has been reported. As enkephalinase inhibitors together with opioid receptor agonists and antagonists modulate the status of the dopaminergic system, the authors assumed that the effect of Selank is mediated by its ability to modulate the status of the endogenous opioid system via changes in the activity of enkephalindegrading enzymes [158].…”
Section: Anxiolytic Effectmentioning
confidence: 99%